Rochester Study Finds Exercise, 200-mg Ibuprofen Ease Chemo Brain in 86 Patients
Updated
Updated · Fox News · May 15
Rochester Study Finds Exercise, 200-mg Ibuprofen Ease Chemo Brain in 86 Patients
3 articles · Updated · Fox News · May 15
Six weeks of home exercise produced the clearest gains in attention and cognitive function among 86 New York adults receiving chemotherapy, while low-dose ibuprofen also outperformed placebo on some measures.
The phase 2 trial split patients into four groups: exercise alone, exercise plus ibuprofen, ibuprofen alone, and placebo; the exercise plan used progressive walking and resistance-band training, and ibuprofen was given at 200 mg twice daily.
Researchers said the stronger exercise effect and smaller, less consistent ibuprofen benefit point to inflammation as a possible driver of chemotherapy-related cognitive impairment, which can affect up to 80% of patients.
No adverse side effects were reported, but the team cautioned that the study was small, short, and mostly female, limiting broader conclusions.
The findings were published in Cancer, and Rochester researchers plan larger phase 3 trials while urging patients to consult oncology teams before starting ibuprofen or exercise during treatment.
A major 2026 study confirms exercise helps "chemo brain." What does this mean for treating other cognitive declines?
Beyond memory, could exercise help cancer patients reclaim the fundamental sense of self lost to "chemo brain"?
2026 Breakthrough: Exercise and Ibuprofen Tested for Chemo Brain in Landmark URMC Study
Overview
Chemo brain, or cancer-related cognitive impairment, affects up to 80% of patients during chemotherapy, causing memory and concentration problems that lower quality of life. This condition is linked to increased proinflammatory cytokine levels, triggered by both cancer and its treatments, which lead to cognitive changes. The latest research highlights the promise of interventions that reduce inflammation, such as exercise and ibuprofen. Exercise, in particular, shows consistent benefits for cognitive function, while ibuprofen’s effects are more nuanced. These findings underscore the need for effective, accessible strategies to help cancer patients manage cognitive side effects during treatment.